Ventyx Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	185	146	1,857	999	-	-
Market Cap Growth	-83.29%	-92.15%	85.92%	-	-	-
Enterprise Value	-109	-95	1,541	740	12	4
PE Ratio	-	-0.76	-17.13	-11.71	-	-
PB Ratio	0.59	0.60	5.25	3.58	-	-
P/FCF Ratio	-1.77	-0.87	-18.75	-25.67	-	-
P/OCF Ratio	-1.78	-0.88	-18.80	-25.84	-	-
EV/EBITDA Ratio	-0.18	0.49	-14.27	-8.85	-0.45	-0.85
EV/EBIT Ratio	-0.18	0.49	-14.21	-8.85	-0.45	-0.85
EV/FCF Ratio	-0.18	0.57	-15.56	-19.03	-2.00	-1.34
Debt / Equity Ratio	0.04	0.05	0.00	-	-0.41	-0.93
Debt / EBITDA Ratio	-0.06	-0.07	-0.01	-	-0.45	-0.92
Debt / FCF Ratio	-0.06	-0.07	-0.02	-	-2.04	-1.46
Quick Ratio	20.89	11.37	19.44	21.05	0.17	0.49
Current Ratio	22.00	11.87	20.21	21.41	0.18	0.55
Interest Coverage	-	-	-	-844.92	-77.70	-28.64
Return on Equity (ROE)	-66.30%	-62.90%	-35.00%	-68.60%	162.00%	-
Return on Assets (ROA)	-60.20%	-57.70%	-32.60%	-58.50%	-9486.20%	-
Return on Capital (ROIC)	-65.06%	-81.11%	-31.83%	-24.05%	39.15%	1482.27%
Earnings Yield	-105.48%	-132.30%	-5.84%	-8.54%	-	-
FCF Yield	-100.69%	-114.53%	-5.33%	-3.90%	-	-
Buyback Yield / Dilution	-7.27%	-11.57%	-309.11%	-544.96%	-19.66%	-
Total Shareholder Return	-7.27%	-11.57%	-309.11%	-544.96%	-19.66%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).